跳至主要内容
临床试验/NCT01411748
NCT01411748Unknown4 期

Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants

Zekai Tahir Burak Women's Health Research and Education Hospital1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
140
试验地点
1
主要终点
Comparison of prophylactic S. boulardii and nystatin on candida colonization and infection in very low birth weight infants

研究概览

简要总结

Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic S boulardii in reducing the candida colonization and infection in very low birth weight infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
1 Day 至 90 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Very low birth weight infants < 1500 gr

排除标准

  • Genetic anomalies
  • Not willing to participate
  • Allergy to S. boulardii components

研究组 & 干预措施

S. boulardii

Experimental

The patients in this group will be given 5 million unit/day S. boulardii until discharge.

干预措施: Reflor (Dietary Supplement)

nystatin

Active Comparator

干预措施: mikostatin (Drug)

结局指标

主要结局

Comparison of prophylactic S. boulardii and nystatin on candida colonization and infection in very low birth weight infants

时间窗: 6 months

次要结局

  • Effect of S. boulardii on sepsis(6 months)

研究者

发起方
Zekai Tahir Burak Women's Health Research and Education Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验